128 results
Page 2 of 7
8-K
EX-10.1
hr7nxxuuyzj qgvwalu
16 Dec 21
Histogen Announces $3.5 Million Private Placement
5:04pm
8-K
EX-10.2
ax04o2hfy2 7lw
16 Dec 21
Histogen Announces $3.5 Million Private Placement
5:04pm
8-K
EX-10.1
c63at7a0hif idb
8 Nov 21
Histogen Announces CEO Transition
4:13pm
8-K
EX-10.1
k4ngl9x
25 Jun 21
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-10.1
aj0xa0cg uw
8 Jun 21
Histogen Announces $6.5 Million Registered Direct Offering
7:44am
8-K
EX-10.3
ihu3fis
8 Jun 21
Histogen Announces $6.5 Million Registered Direct Offering
7:44am
8-K
EX-10.1
raci1 4a8yi7xh4uzq
27 May 21
Departure of Directors or Certain Officers
4:08pm
8-K
EX-10.2
paf5hcqpihsli2op
27 May 21
Departure of Directors or Certain Officers
4:08pm
8-K
EX-10.1
tp8tg9hap
12 Nov 20
Histogen Announces $4.5 Million Registered Direct Offering
8:20am
8-K
EX-10.2
2o2sz3og
12 Nov 20
Histogen Announces $4.5 Million Registered Direct Offering
8:20am
8-K
EX-10.1
fkaqnh
27 Oct 20
Histogen and Amerimmune Enter into a Collaborative Development and Commercialization Agreement for Emricasan in the Treatment of COVID-19
8:05am
8-K
EX-10.1
2l7amh tvghh
20 Jul 20
Histogen Inc. Announces Common Stock Purchase Agreement for up to
4:40pm
8-K
EX-10.2
l60 8uwvmlg7wybw
20 Jul 20
Histogen Inc. Announces Common Stock Purchase Agreement for up to
4:40pm
8-K
EX-10.2
t58x2qeh78
28 May 20
Histogen Appoints Susan A. Knudson as Chief Financial Officer
8:29am
8-K
EX-10.1
2rlrv2jo ddlb2eh
28 May 20
Histogen Appoints Susan A. Knudson as Chief Financial Officer
8:29am
8-K
EX-10.1
zv8du
27 May 20
Histogen Announces Successful Completion of its Merger with Conatus Pharmaceuticals
8:42am
8-K
EX-10.1
sjsk8lr6ijn p2
30 Mar 20
Entry into a Material Definitive Agreement
4:17pm
S-4/A
EX-10.69
wwanhg mvptz3
13 Mar 20
Registration of securities issued in business combination transactions (amended)
5:08pm